Better Therapeutics, Inc. (BTTX) Tops Q1 EPS by 13c

Better Therapeutics, Inc. (NASDAQ: BTTX) reported Q1 EPS of ($0.37), $0.13 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Better Therapeutics, Inc. (BTTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15